Investors Still Aren't Entirely Convinced By The Beauty Health Company's (NASDAQ:SKIN) Revenues Despite 27% Price Jump
Piper Sandler Maintains The Beauty Health(SKIN.US) With Sell Rating, Maintains Target Price $1
Shares of Companies Within the Broader Consumer Staples Sector Are Trading Lower Amid Overall Market Weakness Following the Fed's Rate Decision to Cut Rates by 25 Basis Points.
Express News | Beautyhealth Appoints Stephen J. Fanning to Board of Directors
BeautyHealth Appoints Stephen J. Fanning to Board of Directors
BeautyHealth Releases 2024 Skintuition Report
Glancy Prongay & Murray LLP Announces Investigation of The Beauty Health Company (SKIN) F/k/a Vesper Healthcare Acquisition Corp.
A Quick Look at Today's Ratings for The Beauty Health(SKIN.US), With a Forecast Between $1 to $2
Beauty Health Price Target Raised to $1.75/Share From $1.25 by Canaccord Genuity
Beauty Health Is Maintained at Hold by Canaccord Genuity
Beauty Health Analyst Ratings
Benchmark Co. Remains a Hold on Beauty Health (SKIN)
TD Cowen Maintains The Beauty Health(SKIN.US) With Hold Rating, Cuts Target Price to $2
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript Summary
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript
The Beauty Health | 10-Q: Q3 2024 Earnings Report
The Beauty Health Company Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results.
GUIDANCE: (SKIN) THE BEAUTY HEALTH COMPANY Forecasts Fiscal Year 2024 Revenue Range $322M - $332M
Earnings Flash (SKIN) THE BEAUTY HEALTH COMPANY Reports Q3 Revenue $78.8M
Express News | Beauty Health Co- Qtrly Share Loss $0.15
No Data